956: Efficacy of Tadalafil Dosed Once a Day to Treat Erectile Dysfunction in Men with Comorbid Moderate or Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Abstract
UROLOGy® was 273 days.No significant change from baseline was observed in the prevalence of Complete EjD over time for men on WW; however, the prevalence of Complete EjD increased for men receiving BPH MT (P <0.01 ).CONCLUSIONS: Complete EjD is common in men treated with tamsulosin or a 5ARI, alone or in combination with an alpha-blocker.Men on WW at enrollment had a low rate of Complete EjD and experienced little change in EjD prevalence during a mean 9 months of follow-up.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.